nach oben

Quality of Life Research

Erschienen in:

15.11.2019 | Care

Quality of life in primary care patients with moderate medically unexplained physical symptoms

verfasst von: P. E. van Westrienen, M. F. Pisters, S. A. J. Toonders, M. Gerrits, N. J. de Wit, C. Veenhof

Erschienen in: Quality of Life Research | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Medically Unexplained Physical Symptoms (MUPS) have a large impact on patient’s quality of life. Most studies have been limited to chronic MUPS and thus, little is known about moderate MUPS. Improved knowledge concerning determinants influencing quality of life in moderate MUPS patients can be helpful in managing MUPS. This study is aimed at describing the common characteristics seen in moderate MUPS patients and compare them with characteristics seen in chronic MUPS patients and general population. We also identified determinants of the physical and mental components of quality of life in moderate MUPS patients.

Methods

In a cross-sectional study, moderate MUPS patients (n = 160) were compared with chronic MUPS patients (n = 162) and general population (n = 1742) based on demographic characteristics and patient’s quality of life. Multivariable linear regression analyses were performed to identify determinants associated with a patient’s quality of life, assessed with the RAND-36.

Results

Moderate MUPS patients experienced a better quality of life than chronic MUPS patients, but a worse quality of life as compared to the general population. Determinants associated with the physical and mental components of quality of life explain 49.1% and 62.9% of the variance, respectively.

Conclusion

Quality of life of patients with MUPS varies with MUPS disease stage. Based on their quality of life scores, moderate MUPS patients would be adequately distinguished from chronic MUPS patients. Half of the variance in the physical component and almost two thirds of the mental component would be explained by a number of MUPS-related symptoms and perceptions.

Olde Hartman, T., Blankenstein, A., Molenaar, A., Bentz van den Berg, D., Van der Horst, H., Arnold, I., et al. (2013). NHG-standaard somatisch onvoldoende verklaarde Lichamelijk Klachten (SOLK). Huisarts Wet,56(5), 222–230.

Landelijke Stuurgroep Multidisciplinaire Richtlijnontwikkeling in de GGZ. (2010). Multidisciplinaire Richtlijn Somatisch Onvoldoende Verklaarde Lichamelijke Klachten En Somatoforme Stoornissen (Multidisciplinary Guideline of MUPS and Somatoform Disorders). Utrecht: Netherlands Institute of Mental Health Care and Addiction and Dutch Institute of Health Care Improvement 2010.

Aamland, A., Malterud, K., & Werner, E. (2014). Patients with persistent medically unexplained physical symptoms: A descriptive study from Norwegian general practice. BMC Family Practice,29(15), 107. https://doi.org/10.1186/1471-2296-15-107.CrossRef

Jackson, J., & Passamonti, M. (2005). The outcomes among patients presenting in primary care with a physical symptom at 5 years. Journal of General Internal Medicine,20(11), 1032–1037. https://doi.org/10.1111/j.1525-1497.2005.0241.x.CrossRefPubMedPubMedCentral

Smith, R., & Dwamena, F. (2007). Classification and diagnosis of patients with medically unexplained symptoms. Journal of General Internal Medicine,22(5), 685–691. https://doi.org/10.1007/s11606-006-0067-2.CrossRefPubMedPubMedCentral

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (DSM-5) (5th ed.). Washington: American Psychiatric Press.CrossRef

Barsky, A. J., Orav, E. J., & Bates, D. W. (2005). Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Archives of General Psychiatry,62(8), 903–910. https://doi.org/10.1001/archpsyc.62.8.903.CrossRefPubMed

Verhaak, P., Meijer, S., Visser, A., & Wolters, G. (2006). Persistent presentation of medically unexplained symptoms in general practice. Family Practice,23(4), 414–420. https://doi.org/10.1093/fampra/cml016.CrossRefPubMed

Zonneveld, L. N., Sprangers, M. A., Kooiman, C. G., van ‘t Spijker, A., & Busschbach, J. J. (2013). Patients with unexplained physical symptoms have poorer quality of life and higher costs than other patient groups: A cross-sectional study on burden. BMC Health Services Research,17(13), 520. https://doi.org/10.1186/1472-6963-13-520.CrossRef

10.

Ring, A., Dowrick, C., Humphris, G., & Salmon, P. (2004). Do patients with unexplained physical symptoms pressurise general practitioners for somatic treatment? A qualitative study. BMJ,328(7447), 1057. https://doi.org/10.1136/bmj.38057.622639.EE.CrossRefPubMedPubMedCentral

11.

Olde Hartman, T., Hassink-Franke, L., Dowrick, C., Fortes, S., Lam, C., van der Horst, H., et al. (2008). Medically unexplained symptoms in family medicine: Defining a research agenda. Proceedings from WONCA 2007. Family Practice,25(4), 266–271. https://doi.org/10.1093/fampra/cmn041.CrossRefPubMed

12.

Choy, E., Perrot, S., Leon, T., Kaplan, J., Petersel, D., Ginovker, A., et al. (2010). A patient survey of the impact of fibromyalgia and the journey to diagnosis. BMC Health Services Research,26(10), 102. https://doi.org/10.1186/1472-6963-10-102.CrossRef

13.

Isaac, M., & Paauw, D. (2014). Medically unexplained symptoms. Medical Clinics of North America,98(3), 663–672. https://doi.org/10.1016/j.mcna.2014.01.013.CrossRefPubMed

14.

Olde Hartman, T. C., Hassink-Franke, L. J., Lucassen, P. L., van Spaendonck, K. P., & van Weel, C. (2009). Explanation and relations. How do general practitioners deal with patients with persistent medically unexplained symptoms: A focus group study. BMC Family Practice,24(10), 68. https://doi.org/10.1186/1471-2296-10-68.CrossRef

15.

Kroenke, K., & Jackson, J. (1998). Outcome in general medical patients presenting with common symptoms: A prospective study with a 2-week and a 3-month follow-up. Family Practice,15(5), 398–403.CrossRef

16.

Hoffman, D. L., & Dukes, E. M. (2008). The health status burden of people with fibromyalgia: A review of studies that assessed health status with the SF-36 or the SF-12. International Journal of Clinical Practice,62(1), 115–126. https://doi.org/10.1111/j.1742-1241.2007.01638.x.CrossRefPubMedPubMedCentral

17.

Joustra, M. L., Janssens, K. A., Bültmann, U., & Rosmalen, J. G. (2015). Functional limitations in functional somatic syndromes and well-defined medical diseases. Results from the general population cohort LifeLines. Journal of Psychosomatic Research,79(2), 94–99. https://doi.org/10.1016/j.jpsychores.2015.05.004.CrossRefPubMed

18.

Dirkzwager, A. J., & Verhaak, P. F. (2007). Patients with persistent medically unexplained symptoms in general practice: Characteristics and quality of care. BMC Family Practice. https://doi.org/10.1186/1471-2296-8-33.CrossRefPubMedPubMedCentral

19.

Salaffi, F., Sarzi-Puttini, P., Girolimetti, R., Atzeni, F., Gasparini, S., & Grassi, W. (2009). Health-related quality of life in fibromyalgia patients: A comparison with rheumatoid arthritis patients and the general population using the SF-36 health survey. Clinical and Experimental Rheumatology,27(5 Suppl 56), S67–S74.PubMed

20.

Hanssen, D. J. C., Lucassen, P. L. B. J., Hilderink, P. H., Naarding, P., & Voshaar, R. C. O. (2016). Health-related quality of life in older persons with medically unexplained symptoms. The American Journal of Geriatric Psychiatry,24(11), 1117–1127. https://doi.org/10.1016/j.jagp.2016.07.013.CrossRefPubMed

21.

Fitzcharles, M. A., Rampakakis, E., Ste-Marie, P. A., Sampalis, J. S., & Shir, Y. (2014). The association of socioeconomic status and symptom severity in persons with fibromyalgia. Journal of Rheumatology,41(7), 1398–1404. https://doi.org/10.3899/jrheum.131515.CrossRefPubMed

22.

Reisine, S., Fifield, J., Walsh, S., & Dauser, D. (2004). Employment and quality of life outcomes among women with fibromyalgia compared to healthy controls. Women and Health,39(4), 1–19. https://doi.org/10.1300/J013v39n04_01.CrossRefPubMed

23.

Perrot, S., Schaefer, C., Knight, T., Hufstader, M., Chandran, A., & Zlateva, G. (2012). Societal and individual burden of illness among fibromyalgia patients in France: Association between disease severity and OMERACT core domains. BMC Musculoskeletal Disorders. https://doi.org/10.1186/1471-2474-13-22.CrossRefPubMedPubMedCentral

24.

Rusu, C., Gee, M. E., Lagacé, C., & Parlor, M. (2015). Chronic fatigue syndrome and fibromyalgia in Canada: Prevalence and associations with six health status indicators. Health Promotion and Chronic Disease Prevention in Canada,35(1), 3–11.CrossRef

25.

Campos, R. P., & Vázquez, M. I. (2013). The impact of Fibromyalgia on health-related quality of life in patients according to age. Rheumatology International,33(6), 1419–1424. https://doi.org/10.1007/s00296-012-2568-0.CrossRefPubMed

26.

van Wilgen, C. P., van Ittersum, M. W., Kaptein, A. A., & van Wijhe, M. (2008). Illness perceptions in patients with fibromyalgia and their relationship to quality of life and catastrophizing. Arthritis and Rheumatism,58(11), 3618–3626. https://doi.org/10.1002/art.23959.CrossRefPubMed

27.

Soriano-Maldonado, A., Amris, K., Ortega, F. B., Segura-Jiménez, V., Estévez-López, F., Álvarez-Gallardo, I. C., et al. (2015). Association of different levels of depressive symptoms with symptomatology, overall disease severity, and quality of life in women with fibromyalgia. Quality of Life Research,24(12), 2951–2957. https://doi.org/10.1007/s11136-015-1045-0.CrossRefPubMed

28.

Busch, A., Barber, K., Overend, T., Peloso, P., & Schachter, C. (2007). Exercise for treating fibromyalgia syndrome. Cochrane Database Systematic Review,17, 4. https://doi.org/10.1002/14651858.CD003786.pub2.CrossRef

29.

Bernardy, K., Klose, P., Welsch, P., & Häuser, W. (2018). Efficacy, acceptability and safety of cognitive behavioural therapies in fibromyalgia syndrome—A systematic review and meta-analysis of randomized controlled trials. European Journal of Pain,22(2), 242–260. https://doi.org/10.1002/ejp.1121.CrossRefPubMed

30.

Henningsen, P., Zipfel, S., & Herzog, W. (2007). Management of functional somatic syndromes. Lancet,369(9565), 946–955. https://doi.org/10.1016/s0140-6736(07)60159-7.CrossRefPubMed

31.

Price, J., Mitchell, E., Tidy, E., & Hunot, V. (2008). Cognitive behaviour therapy for chronic fatigue syndrome in adults. Cochrane Database Systematic Review. https://doi.org/10.1002/14651858.cd001027.pub2.CrossRef

32.

Larun, L., Brurberg, K., Odgaard-Jensen, J., & Price, J. (2017). Exercise therapy for chronic fatigue syndrome. Cochrane Database Systematic Review,25, 4. https://doi.org/10.1002/14651858.CD003200.pub7.CrossRef

33.

Henningsen, P. (2018). Management of somatic symptom disorder. Dialogues in Clinical Neuroscience,20(1), 23–31.PubMedPubMedCentral

34.

van Dessel, N., den Boeft, M., van der Wouden, J. C., Kleinstäuber, M., Leone, S. S., Terluin, B., et al. (2014). Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults. Cochrane Database Systematic Review. https://doi.org/10.1002/14651858.cd011142.pub2.CrossRef

35.

van Westrienen, P. E., Pisters, M. F., Toonders, S. A., Gerrits, M., Veenhof, C., & de Wit, N. J. (2018). Effectiveness of a blended multidisciplinary intervention for patients with moderate medically unexplained physical symptoms (PARASOL): Protocol for a cluster randomized clinical trial. JMIR Research Protocols. https://doi.org/10.2196/resprot.9404.CrossRefPubMedPubMedCentral

36.

Aaronson, N. K., Muller, M., Cohen, P. D., Essink-Bot, M. L., Fekkes, M., Sanderman, R., et al. (1998). Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. Journal of Clinical Epidemiology,51(11), 1055–1068.CrossRef

37.

Van der Zee, K. I., Sanderman, R. (1993). Het meten van de algemene gezondheidstoestandmet de RAND-36, een handleiding (Measurement of general healthwith the RAND-36, amanual). Groningen, the Netherlands: Noordelijk Centrum voor Gezondheidsvraagstukken; 1993.

38.

Van der Zee, K. I., Sanderman, R., Heyink, J. W., & de Haes, H. (1996). Psychometric qualities of the RAND 36-Item Health Survey 1.0: A multidimensional measure of general health status. International Journal of Behavioral Medicine,3(2), 104–122. https://doi.org/10.1207/s15327558ijbm0302_2.CrossRef

39.

Ware, J. E. J., & Gandek, B. (1998). Overview of the SF-36 health survey and the International Quality of Life Assessment (IQOLA) Project. Journal of Clinical Epidemiology,51(11), 903–912.CrossRef

40.

Ware, J. E. J., Gandek, B., Kosinski, M., Aaronson, N. K., Apolone, G., Brazier, J., et al. (1998). The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: Results from the IQOLA Project. International Quality of Life Assessment. Journal of Clinical Epidemiology,51(11), 1167–1170.CrossRef

41.

Dworkin, R., Turk, D., Wyrwich, K., Beaton, D., Cleeland, C., Farrar, J., et al. (2008). Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. The Journal of Pain,9(2), 105–121. https://doi.org/10.1016/j.jpain.2007.09.005.CrossRefPubMed

42.

Terluin, B., van Marwijk, H., Adèr, H., de Vet, H., Penninx, B., Hermens, M., et al. (2006). The Four-Dimensional Symptom Questionnaire (4DSQ): A validation study of a multidimensional self-report questionnaire to assess distress, depression, anxiety and somatization. BMC Psychiatry,22(6), 34. https://doi.org/10.1186/1471-244X-6-34.CrossRef

43.

De, Terluin B. (1996). Vierdimensionale Klachtenlijst (4DKL): Een vragenlijst voor het meten van distress, depressie, angst en somatisatie. Huisarts Wet,39, 538–547.

44.

Terluin, B., Terluin, M., Prince, K., & van Marwijk, H. W. J. (2008). The Four-Dimensional Symptom Questionnaire (4DSQ) detects psychological problems. Huisarts Wet,51, 251–255.CrossRef

45.

Terluin, B., Oosterbaan, D. B., Brouwers, E. P., van Straten, A., van de Ven, P. M., Langerak, W., et al. (2014). To what extent does the anxiety scale of the Four-Dimensional Symptom Questionnaire (4DSQ) detect specific types of anxiety disorder in primary care? A psychometric study. BMC Psychiatry,24(12), 121. https://doi.org/10.1186/1471-244X-14-121.CrossRef

46.

Broadbent, E., Petrie, K. J., Main, J., & Weinman, J. (2006). The brief illness perception questionnaire. Journal of Psychosomatic Research,60(6), 631–637. https://doi.org/10.1016/j.jpsychores.2005.10.020.CrossRefPubMed

47.

Bussmann, H. (2013). Validation of the Active8 activity monitor: Detection of body postures and movements. Erasmus MC: Publisher.

48.

Choi, L., Ward, S. C., Schnelle, J. F., & Buchowski, M. S. (2012). Assessment of wear/nonwear time classification algorithms for triaxial accelerometer. Medicine and Science in Sports and Exercise,44(10), 2009–2016. https://doi.org/10.1249/MSS.0b013e318258cb36.CrossRefPubMedPubMedCentral

49.

Matthews, C. E., Chen, K. Y., Freedson, P. S., Buchowski, M. S., Beech, B. M., Pate, R. R., et al. (2008). Amount of time spent in sedentary behaviors in the United States, 2003-2004. American Journal of Epidemiology,167(7), 875–881. https://doi.org/10.1093/aje/kwm390.CrossRefPubMedPubMedCentral

50.

Tremblay, M. S., Aubert, S., Barnes, J. D., Saunders, T. J., Carson, V., Latimer-Cheung, A. E., et al. (2017). Sedentary behavior research network (SBRN)—Terminology consensus project process and outcome. International Journal of Behavioral Nutrition and Physical Activity,14(1), 75. https://doi.org/10.1186/s12966-017-0525-8.CrossRefPubMed

51.

Health Council of the Netherlands. (2017). Physical activity guidelines 2017. The Hague: Health Council of the Netherlands, 2017;publication no. 2017/08e.

52.

Divisie Sociale en ruimtelijke statistieken Sector Sociaal-economisch totaalbeeld. (2017). Standaard onderwijsindeling 2006—Editie 2016/’17. Centraal Bureau voor de Statistiek, Den Haag/Heerlen; 2017:10–14.

53.

Azur, M. J., Stuart, E. A., Frangakis, C., & Leaf, P. J. (2011). Multiple imputation by chained equations: What is it and how does it work? International Journal of Methods in Psychiatric Research,20(1), 40–49. https://doi.org/10.1002/mpr.329.CrossRefPubMedPubMedCentral

54.

Miles, J., & Shevlin, M. (2001). Applying regression and correlation. A guide for students and researchers (2nd ed.). London: SAGE Publications Ltd.

55.

Ware, J. E., Snow, K. K., Kosinski, M., & Gandek, B. (1993). SF-36 health survey manual and interpretation guide. Boston, MA: New England Medical Center, The Health Institute.

56.

Gross, T., Morell, S., & Amsler, F. (2018). Longer-term quality of life following major trauma: Age only significantly affects outcome after the age of 80 years. Clinical Interventions in Aging,30(13), 773–785. https://doi.org/10.2147/CIA.S158344.CrossRef

57.

Togas, C., Raikou, M., & Niakas, D. (2014). An assessment of health related quality of life in a male prison population in Greece associations with health related characteristics and characteristics of detention. BioMed Research International,2014, 274804. https://doi.org/10.1155/2014/274804.CrossRefPubMedPubMedCentral

58.

Lee, J. W., Lee, K. E., Park, D. J., Kim, S. H., Nah, S. S., Lee, J. H., et al. (2017). Determinants of quality of life in patients with fibromyalgia: A structural equation modeling approach. PLoS ONE,12(2), e0171186. https://doi.org/10.1371/journal.pone.0171186.CrossRefPubMedPubMedCentral

59.

Poloni, N., Ielmini, M., Caselli, I., Ceccon, F., Bianchi, L., Isella, C., et al. (2018). Medically unexplained physical symptoms in hospitalized patients: A 9-year retrospective observational study. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2018.00626.CrossRefPubMedPubMedCentral

60.

van der van Eck Sluijs, J. F., Ten Have, M., de Graaf, R., Rijnders, C. A. T., van Marwijk, H. W. J., & van der Feltz-Cornelis, C. M. (2018). Predictors of persistent medically unexplained physical symptoms: Findings from a general population study. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2018.00613-&gt.CrossRef

Titel: Quality of life in primary care patients with moderate medically unexplained physical symptoms
verfasst von: P. E. van Westrienen
M. F. Pisters
S. A. J. Toonders
M. Gerrits
N. J. de Wit
C. Veenhof
Publikationsdatum: 15.11.2019
Verlag: Springer International Publishing
Schlagwort: Care
Erschienen in: Quality of Life Research / Ausgabe 3/2020
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-019-02358-8

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2020

Psychometric evaluation of the Participation and Activity Inventory for Children and Youth (PAI-CY) 0–2 years with visual impairment

Health-related quality of life in South Korean community-dwelling older adults with multimorbidity: a convergent parallel mixed-methods approach

Is quality of life after mastectomy comparable to that after breast conservation surgery? A 5-year follow up study from Mumbai, India

Cross-cultural adaptation, reliability, and construct validity of the Thai version of the Patient-Reported Outcomes Measurement Information System-29 in individuals with chronic low back pain

Responsiveness and minimal clinically important difference of TNO-AZL Preschool Children Quality of Life in children with cerebral palsy

Correlation between disease severity factors and EQ-5D utilities in chronic obstructive pulmonary disease